HOME >> MEDICINE >> NEWS
Drug regimen adherence key in keeping babies virus-free, study suggests

COLUMBUS, Ohio - The best available defense against serious lower respiratory infections in infants is a drug that can cost the consumer more than $2,000 a treatment.

That cost may prove problematic for some parents, said Diane Langkamp, co-author of a study that looked at the factors affecting compliance with the drug palivizumab (brand name Synagis). Langkamp did the study while an assistant professor of pediatrics at Ohio State University.

Palivizumab reduces an infant's risk of developing respiratory syncytial virus (RSV). RSV causes minor upper respiratory illnesses - such as colds - in older children and adults. But it can cause serious lower respiratory illnesses - such as pneumonia or bronchiolitis - in babies born prematurely or those with chronic lung disease.

Also, palivizumab must be given monthly during the RSV season, which starts in November in Ohio and usually lasts five months. Therefore, a season's treatment could cost more than $10,000. RSV is spread through person-to-person contact. "Palivizumab is a very effective preventive measure," said Langkamp, now director of the neonatal follow-up program at Children's Hospital Medical Center of Akron. "The drug is reserved for children two years of age and younger, and then only for those babies whose lungs aren't fully developed or have other complications.


'"/>

Contact: Diane Langkamp
Dlangkamp@chmca.org
330-543-8261
Ohio State University
8-Nov-2001


Page: 1 2 3

Related medicine news :

1. Study examines three-day antibiotic regimens for treating bladder infection in women
2. Study assessing once daily Abacavir (ABC) in a once daily ART regimen
3. Study compares three weekly regimens of chemotherapy for lung cancer
4. Vitamin E fails to join heart-health regimen
5. Newer lung cancer treatments extend survival longer than traditional regimens
6. New drug regimen shows clear benefit for treating advanced colorectal cancer
7. Emory University will conduct clinical trial of anthrax vaccine regimen
8. 7-day-on, 7-day-off regimen could reduce cost, toxicities of HIV therapy
9. HIV patients more likely to accept a drug regimen if they trust in the physician, Yale researchers find
10. Are people with HIV sticking to their medication treatment regimens? New method measures patient adherence
11. Study compares efficacy and adherence to triple nucleoside therapy Ziagen + Combivir with protease inhibitor plus Combivir regimens in therapy-nave

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/12/2019)... ... 2019 , ... Remote Medical Technologies (RMT) will be a ... Annual Meeting being held in National Harbor, Maryland on March 18th to the ... RMT’s Mobile-Cart Solution . These solutions are high-performance HD telepathology systems ...
(Date:3/12/2019)... ... 12, 2019 , ... Caring Transitions is pleased to recognize Caring Transitions North ... owned by mother/daughter team Donna and Nicole Rea with the support of their team. ... Donna and Nicole of Caring Transitions of North Dallas Suburbs drove them to be ...
(Date:3/12/2019)... ... March 12, 2019 , ... When it comes to selecting ... to treat pain and diseases of joints, muscles, tendons and ligaments, “choose wisely,” ... the movie Indiana Jones. , “Some clinics and health centers have been built ...
(Date:3/12/2019)... , ... March 12, 2019 , ... A recent report ... facilities. Focusing on a series of Idaho case studies, the report argues that charter ... These arguments, while focused on Idaho in this particular report, have been made with ...
(Date:3/12/2019)... ... March 12, 2019 , ... The U.S. healthcare industry has ... each patient moving through different care settings. With a shared goal of providing ... ® today announced its support for broader discussions about the unique patient identifier ...
Breaking Medicine News(10 mins):
(Date:3/17/2019)... ... March 17, 2019 , ... The arthroscopic ... restored shoulder function and the opportunity to return to sports and physically-demanding work, ... Las Vegas, Nevada. The study, which examined patient outcomes up to five years ...
(Date:3/16/2019)... , ... March 16, 2019 , ... ... excited to announce the hiring of Sabrina Kautz as their new VP of ... leadership role in the company as they experience unprecedented growth and new product ...
(Date:3/15/2019)... ... March 15, 2019 , ... Dr. Srini Pillay , a best-selling author, ... chunk of his career subverting ideas on creativity and the processes behind human thinking. ... hit since its original release in 2017. , Now, Pillay is stating that creativity ...
Breaking Medicine Technology:
Cached News: